f-Information measures for efficient selection of discriminative genes from microarray data.
Where this comes from
- Record sourced from PubMed, PMID 19272938.
- Also identified by DOI 10.1109/TBME.2008.2004502.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among the great amount of genes presented in microarray gene expression data, only a small fraction is effective for performing a certain diagnostic test. In this regard, mutual information has been shown to be successful for selecting a set of relevant and nonredundant genes from microarray data. However, information theory offers many more measures such as the f-information measures that may be suitable for selection of genes from microarray gene expression data. This paper presents different f-information measures as the evaluation criteria for gene selection problem. To compute the gene-gene redundancy (respectively, gene-class relevance), these information measures calculate the divergence of the joint distribution of two genes' expression values (respectively, the expression values of a gene and the class labels of samples) from the joint distribution when two genes (respectively, the gene and class label) are considered to be completely independent. The performance of different f-information measures is compared with that of the mutual information based on the predictive accuracy of naive Bayes classifier, K -nearest neighbor rule, and support vector machine. An important finding is that some f-information measures are shown to be effective for selecting relevant and nonredundant genes from microarray data. The effectiveness of different f-information measures, along with a comparison with mutual information, is demonstrated on breast cancer, leukemia, and colon cancer datasets. While some f -information measures provide 100% prediction accuracy for all three microarray datasets, mutual information attains this accuracy only for breast cancer dataset, and 98.6% and 93.6% for leukemia and colon cancer datasets, respectively.
Medical subject headings
- Models, Genetic
- Oligonucleotide Array Sequence Analysis